Treatment status | |||||
Characteristic | All patients (N = 235) | Experienced (N = 152) | Naïve (N = 83) | P value T test | P value Wilcoxon rank sum test |
Mean (SD) age (years) | 41.0 (10.0) | 42.6 (9.5) | 37.9 (10.2) | 0.0006 | <0.0001 |
Mean (SD) weight (kg) | 63.1 (13.4) | 64.9 (13.1) | 59.6 (13.2) | 0.0038 | 0.0082 |
Mean (SD) BMI (kg/m2) | 23.4 (4.7) | 24.2 (4.7) | 21.8 (4.5) | 0.0001 | 0.0002 |
Mean (SD) CD4 count (cells/uL) | 460.7 (322) | 513 (304) | 363 (334) | 0.0006 | <0.0001 |
n (%) | n (%) | n (%) | P value Chi square | P value Fisher | |
Sex | 0.597 | 0.677 | |||
Female | 139 (59.1) | 88 (57.9) | 51 (61.5) | ||
Male | 96 (40.9) | 64 (42.1) | 32 (38.6) | ||
Ethnicity | 0.744 | 0.762 | |||
Akan | 109 (46.8) | 72 (47.4) | 37 (45.7) | ||
Ewe | 44 (18.9) | 29 (19.1) | 15 (18.5) | ||
Ga | 28 (12.0) | 20 (13.1) | 8 (9.9) | ||
Other | 52 (22.3) | 31 (20.4) | 21 (25.9) | ||
WHO HIV stage | 0.630 | 0.619 | |||
1 | 55 (23.7) | 38 (25.3) | 17 (20.7) | ||
2 | 58 (25.0) | 36 (24.0) | 22 (26.8) | ||
3 | 92 (39.7) | 61 (40.7) | 31 (37.8) | ||
4 | 27 (11.6) | 15 (10.0) | 12 (14.6) | ||
HBeAg positive | 47 (20.0) | 28 (18.4) | 19 (22.9) | 0.413 | 0.495 |
HBeAb positive | 188 (80.0) | 122 (80.3) | 66 (79.5) | 0.891 | 1.000 |
HBeAg/eAb combination | 0.622 | 0.604 | |||
HBeAg positive/Ab negative | 41 (17.5) | 25 (16.5) | 16 (19.3) | ||
HBeAg negative/Ab positive | 182 (77.5) | 119 (78.3) | 63 (75.9) | ||
HBeAg negative/Ab negative | 6 (2.6) | 5 (3.3) | 1 (1.2) | ||
HBcIgM positive | 5 (2.1) | 4 (2.6) | 1 (1.2) | 0.469 | 0.659 |
Treatment status | |||||
Characteristic | All patients | Experienced | Naïve | P value Chi square | P value Fisher |
N = 235 (%) | (N = 152) | (N = 83) | |||
n (%) | n (%) | ||||
Alanine aminotransferase | 0.0012 | 0.0015 | |||
Normal (5-40 U/L) | 169 (71.9) | 120 (79.0) | 49 (59.0) | ||
Elevated > ULN | 66 (28.1) | 32 (21.1) | 34 (41.0) | ||
Aspartate aminotransferase | 0.0005 | 0.0008 | |||
Normal (5-50 U/L) | 178 (75.7) | 126 (82.9) | 52 (62.7) | ||
Elevated > ULN | 57 (24.3) | 26 (17.1) | 30 (36.1) | ||
Albumin | <0.0001 | <0.0001 | |||
Normal (36-50) | 153 (65.1) | 117 (77.0) | 36 (43.4) | ||
Low < LLN | 82 (34.9) | 35 (23.0) | 47 (56.6) | ||
HBV DNA (IU mL-1) | <0.0001 | <0.0001 | |||
< 20 | 97 (41.3) | 88 (57.9) | 9 (10.8) | ||
20 – 2000 | 58 (24.7) | 31 (20.4) | 27 (32.5) | ||
2001 - 20, 000 | 14 (6.0) | 4 (2.6) | 10 (12.1) | ||
> 20, 000 | 66 (28.1) | 29 (19.1) | 37 (44.6) | ||
Initial ART contain | |||||
3TC | 100 (42.6) | 100 (65.8) | -- | ||
3TC + TDF | 52 (22.1) | 52 (34.2) | -- | ||
Duration on ART | -- | ||||
<1 year | 4 (1.7) | 4 (2.6) | |||
1 – 2 years | 38 (16.2) | 38 (25.0) | -- | ||
2 – 3 years | 21 (8.9) | 21 (13.8) | -- | ||
> 3 years | 89 (37.9) | 89 (58.6) | -- | ||
Ever forgotten meds? | 36 (23.7) | -- | |||
Do you take meds on time? | 16 (10.5) | -- | |||
Stop taking meds due to illness? | 12 (7.9) | -- | |||
Forgotten meds last weekend? | 14 (9.2) | -- | |||
Number of times not taken meds last week? | |||||
0 | 57 (37.5) | ||||
1 to 2 | 10 (6.6) | ||||
3 – 5 | 6 (3.9) | ||||
more than 5 | 3 (2.0) |